TITLE

Lupus nephritis: a challenging cause of rapidly progressive crescentic glomerulonephritis

AUTHOR(S)

Sumethkul, V.; Chalermsanyakorn, P.; Changsirikulchai, S.; Radinahamed, P.

PUB. DATE

June 2000

SOURCE

Lupus;2000, Vol. 9 Issue 6, p424

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

The outcomes of 32 lupus patients with rapidly progressive crescentic glomerulonephritis were studied. Lupus nephritis accounted for 51.6% (32/62) of all patients with biopsy proven rapidly progressive crescentic glomerulonephritis during a six year observation period that includes 961 consecutive native kidney biopsies. Median entry serum creatinine was 221 �mol/1. All patients received induction therapy with pulse methylprednisolone (n=27) or intravenous cyclophosphamide (n=5). Maintenance therapies included prednisolone alone (group 1), prednisolone plus intermittent pulse intravenous cyclophosphamide (IVCY) (group 2) and prednisolone plus daily oral cytotoxic drugs (group 3). Twelve patients eventually had uremia. Seven further patients died of infection during therapy. One patient still had renal insufficiency and twelve patients had favorable clinical outcome (serum creatinine <200 �mol/1). Patients in group 3 were more likely to have favorable clinical outcome than group 2 (P=0.01; Fisher's exact test). Survival analysis found that the three year survival of �group 2� was 27.6% while that of �group 3� was 83.3%. Our results suggest that lupus nephritis is not an infrequent cause of crescentic glomerulonephritis. Therapy with IVCY is not necessary associated with good outcome. Selected patients can be effectively treated with daily oral cytotoxic drugs as a reasonable alternative therapy. Lupus (2000) 9, 424�428.

ACCESSION #

5004095

Tags: LUPUS nephritis;  BIOPSY;  GLOMERULONEPHRITIS

 

Related Articles

• Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy. Dimitrijevic, Jovan; �ukanovic, Ljubica; Kovacevic, Zoran; Bogdanovic, Radovan; Maksic, �oko; Hrvacevic, Rajko; Aleksic, Anastasija; Naumovic, Radomir; Jovanovic, Dijana; Braju�kovic, Goran; Milosavljevic, Ivica // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Nov/Dec2002, Vol. 59 Issue 6, p21 

  Lupus nephritis (LN) is one of the most significant manifestations in systemic lupus erythematosus (SLE), although in some cases there is no direct correlation among clinical, serologic and histologic findings. Therefore, renal biopsy and histopathologic classification by the activity and...

• MMF May Decrease Binding of Immune Complexes in the Glomerular Capillary Wall.  // Kidney;Mar/Apr99, Vol. 8 Issue 2, p54 

  Assesses the effect of mycophenolate mofetil (MMF) on proteinuria, on histologic severity of glomerulonephritis (GN) and on glomerular immunoglobin and complement deposition in a mouse model of lupus nephritis (LN). Reduction of the incidence of albuminuria; Immune-modulating effects observed...

• Letter to the Editor. Matthews, SB; Kallarackal, G; Shortt, M; Pritchard, MH // Lupus;2002, Vol. 11 Issue 1, p64 

  Reports the usefulness of chemoadsorption apheresis as therapy for lupus nephritis. Background on the patient; Treatment given to the patient; Significance of the case study.

• Review of ACR renal criteria in systemic lupus erythematosus. Dooley, M A.; Aranow, C.; Ginzler, E M. // Lupus;2004, Vol. 13 Issue 11, p857 

  The American College of Rheumatology renal criteria require re-evaluation to incorporate recent advances in the classification of glomerulonephritidies. Renal biopsy is now common and safely performed by experienced nephrologists in community as well as academic settings. The optimal criterion...

• Prediction of urinary protein markers in lupus nephritis. Oates, Jim C.; Varghese, Sanju; Bland, Alison M.; Taylor, Timothy P.; Self, Sally E.; Stanislaus, Romesh; Almeida, Jonas S.; Arthur, John M. // Kidney International;Dec2005, Vol. 68 Issue 6, p2588 

  Background. Lupus nephritis is divided into six classes and scored according to activity and chronicity indices based on histologic findings. Treatment differs based on the pathologic findings. Renal biopsy is currently the only way to accurately predict class and activity and chronicity...

• Clinicopathological correlations of paediatric lupus nephritis. Marks, Stephen D.; Sebire, Neil J.; Pilkington, Clarissa; Tullus, Kjell // Pediatric Nephrology;Jan2007, Vol. 22 Issue 1, p77 

  The International Society of Nephrology and Renal Pathology Society Working Group revised the histopathological classification of lupus nephritis (LN) in 2003. We studied the clinical outcome of 39 children (85% female) aged 3.3-18.0 (median 13.7) years who underwent 49 percutaneous renal...

• Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy. Askenazi, David; Myones, Barry; Kamdar, Ankur; Warren, Robert; Perez, Maria; Guzman, Marietta; Minta, Anna; Hicks, M.; Kale, Arundhati // Pediatric Nephrology;Jul2007, Vol. 22 Issue 7, p981 

  Outcomes in children with proliferate lupus nephritis (PLN) show 9�15% progress to end-stage renal disease (ESRD) at 5 years. Immunosuppression improves outcome, but significant side effects are possible. Clinical and laboratory analyses are poor predictors of class and progression in PLN. We...

• Renal-limited �lupus-like� nephritis. Huerta, Ana; Bomback, Andrew S.; Liakopoulos, Vassilis; Palanisamy, Amudha; Stokes, M. Barry; D�Agati, Vivette D.; Radhakrishnan, Jai; Markowitz, Glen S.; Appel, Gerald B. // Nephrology Dialysis Transplantation;Jun2012, Vol. 27 Issue 6, p2337 

  In the setting of an IgG-dominant immune complex-mediated glomerulonephritis, there are multiple pathological findings that strongly suggest the diagnosis of lupus nephritis (LN) including (i) �full-house� immunofluorescence staining for IgG, IgM, IgA, C3 and C1; (ii) extraglomerular immune...

• Renal biopsy in lupus nephritis. Grande, J.P.; Balow, J.E. // Lupus;1998, Vol. 7 Issue 9, p611 

  Renal biopsy can be extremely valuable in the management of patients with lupus nephritis. It is remarkably common to find pathological evidence of substantial nephron loss in patients with low-grade laboratory abnormalities. This is due to compensatory hypertrophy and hemodynamic adjustments...

Read the Article